ArticleBMC complementary medicine and therapies2026
Preclinical evaluation of Senna alata leaf extract against Hymenolepis diminuta: a promising natural anthelmintic solution.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSenna alata is widely recognized for its wide range of therapeutic benefits, including its antioxidant activity. Our previous research demonstrated its non-toxic nature in mice and its modulatory effects on the antioxidant system of the zoonotic parasite Hymenolepis diminuta. However, understanding the mode of action of S. alata during active parasitic infection is essential for evaluating its antiparasitic potential. This study aims to explore the in vivo efficacy of alcoholic leaf extract of S. alata against H. diminuta infection in a rodent model, focusing on both antiparasitic activity and host health parameters, which make it a promising candidate for further therapeutic exploration.
methodsThe in vivo studies on S. alata leaf extract provided important preclinical insights into its antiparasitic mechanism against H. diminuta. Male Swiss albino rats were pre-infected with cysticercoid larvae of H. diminuta and subsequently treated orally post 22 days of infection with alcoholic leaf extract of S. alata at doses of 250, 500, and 1000 mg/kg body weight. Faecal egg counts were monitored daily until the end of the experiment to assess the parasitic burden. Haematological parameters along with liver and kidney function markers were analysed in both treated and untreated control groups to evaluate the host's physiological response and overall health.
resultsThe 1000 mg/kg dose of S. alata extract resulted in a complete reduction in faecal egg count and full elimination of parasites from the small intestine. All the treatment doses significantly alleviated H. diminuta-induced anemia and ameliorated hepatic and renal impairments in infected rats. The extract showed no signs of systemic toxicity across all concentrations used.
conclusionThis study demonstrates the potent antiparasitic effects of S. alata against H. diminuta in a rodent model. The alcoholic leaf extract of S. alata, particularly at 1000 mg/kg, exhibits strong antiparasitic efficacy against H. diminuta, alongside notable improvements in host hematological and organ function parameters. Its non-toxic nature reinforces its potential as a safe, natural anthelmintic, warranting further exploration for therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.